US declines to approve first MDMA-based PTSD treatment
The U.S. Food and Drug Administration has declined to approve a therapy based on the mind-altering drug MDMA for patients with post-traumatic stress disorder, stating it could not be approved based on the data submitted, developer Lykos Therapeutics said Friday. Commonly known as ecstasy or molly, MDMA has long been seen by advocates as a … Read more